An alert recently went out regarding an experimental procedure that uses balloon angioplasty devices outside the scope of the agency’s approved indications for use. Transvascular autonomic modulation involves the threading of a catheter into a patient’s venous system and inflating a balloon attached to the catheter in order to widen the vein walls. In this use, one physician has claimed the method treats the signs and symptoms of autonomic dysfunction in some neurological disorders. However, FDA has not reviewed data that supports the safe and effective use of balloon angioplasty devices for this approach.
Healthcare professionals and patients are encourage to report adverse events via the MedWatch Safety Information and Adverse Event Reporting Program.
Find the fake news: This article is part of the MedTech Intelligence April Fool’s edition. Vote on whether or not this is fake news by taking our poll, which will appear on our homepage on April Fool’s Day.
Related Articles
-
FDA has issued a safety communication to alert patients and healthcare providers about the dangers of inappropriate use of NIPS tests.
-
Mitigating risk of failure is one of the most important disciplines to perform for medical device manufacturers, and for the last couple of years, it has become an increasingly difficult discipline to master.
-
Remote care in the home relies both on the quality of patient monitoring and on the insights provided to the care team. There is a real danger that data overload and alert fatigue will undermine otherwise well-designed remote patient monitoring…
-
New data presented at the Technology and Heart Failure Therapeutics (THT) Conference showed that hemodynamic monitoring can slow the progression of heart failure in patients with reduced ejection fraction.
